Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Parentheticals)

v3.23.1
Consolidated Balance Sheets (Parentheticals) - USD ($)
shares in Thousands, $ in Thousands
Mar. 31, 2023
Dec. 31, 2022
 [1]
Accounts receivable, net of allowance (in Dollars) $ 66 $ 105
Preferred stock, par value (in Dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized 10,000 10,000
Preferred stock, liquidation preference (in Dollars) $ 18,075 $ 18,075
Common stock, par value (in Dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized 300,000 300,000
Common stock, shares issued 76,187 75,154
Common stock, shares outstanding 76,187 75,154
Series A Preferred Stock    
Preferred stock, shares authorized 1,684 1,684
Preferred stock, shares issued
Preferred stock, shares outstanding
Series B Preferred Stock    
Preferred stock, shares authorized 1,581 1,581
Preferred stock, shares issued 927 927
Preferred stock, shares outstanding 927 927
Non-voting common stock    
Common stock, par value (in Dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized 3,553 3,553
Common stock, shares issued 1 1
Common stock, shares outstanding 1 1
[1] Amounts derived from the audited financial statements for the year ended December 31, 2022.